Shattuck Labs (STTK) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free STTK Stock Alerts $10.42 -0.24 (-2.25%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineShattuck Labs Inc (STTK)investing.com - May 9 at 5:49 PMShattuck Labs (NASDAQ:STTK) Rating Reiterated by Needham & Company LLCamericanbankingnews.com - May 7 at 5:18 AMHC Wainwright Reiterates "Buy" Rating for Shattuck Labs (NASDAQ:STTK)americanbankingnews.com - May 6 at 6:14 AMShattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Resultsfinance.yahoo.com - May 4 at 5:55 PMShattuck Labs First Quarter 2024 Earnings: Beats Expectationsfinance.yahoo.com - May 4 at 5:55 PMShattuck Labs (NASDAQ:STTK) Posts Earnings Results, Beats Estimates By $0.08 EPSmarketbeat.com - May 3 at 8:51 PMShattuck Labs (NASDAQ:STTK) Given Buy Rating at Needham & Company LLCmarketbeat.com - May 3 at 11:12 AMSTTK Stock Earnings: Shattuck Labs Beats EPS, Beats Revenue for Q1 2024investorplace.com - May 2 at 10:03 PMShattuck Labs: Buy Rating Affirmed on Strong Q1 Financials and Promising Clinical Milestonesmarkets.businessinsider.com - May 2 at 7:48 PMBuy Rating Affirmed for Shattuck Labs Ahead of Key Clinical Trial Updates on SL-172154markets.businessinsider.com - May 2 at 7:48 PMShattuck Labs (NASDAQ:STTK) Given "Buy" Rating at HC Wainwrightmarketbeat.com - May 2 at 2:39 PMShattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlightsglobenewswire.com - May 2 at 7:05 AMShattuck Labs (NASDAQ:STTK) Reaches New 1-Year High at $11.19americanbankingnews.com - May 1 at 9:58 AMShattuck Labs (NASDAQ:STTK) Reaches New 12-Month High at $11.19marketbeat.com - April 29 at 9:46 AMSTTK May 2024 7.500 callca.finance.yahoo.com - April 20 at 7:25 AMOwning 36% shares,institutional owners seem interested in Shattuck Labs, Inc. (NASDAQ:STTK),finance.yahoo.com - April 18 at 1:06 PMShattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024globenewswire.com - April 9 at 4:05 PMStrong Buy Rating for Shattuck Labs on Innovative Immunotherapy Pipeline and Leadershipmarkets.businessinsider.com - April 9 at 3:39 PMShattuck Labs (NASDAQ:STTK) Stock Rating Reaffirmed by Needham & Company LLCmarketbeat.com - April 9 at 8:30 AMShattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conferenceglobenewswire.com - April 1 at 7:00 AMSTTK Apr 2024 17.500 callfinance.yahoo.com - March 16 at 9:05 PMSTTK Apr 2024 7.500 putfinance.yahoo.com - March 16 at 9:05 PMInsider Selling: Shattuck Labs, Inc. (NASDAQ:STTK) Insider Sells 16,004 Shares of Stockinsidertrades.com - March 11 at 7:00 AMShattuck Labs Full Year 2023 Earnings: Beats Expectationsfinance.yahoo.com - March 6 at 7:15 PMShattuck Labs (NASDAQ:STTK) Sets New 52-Week High at $11.11marketbeat.com - March 6 at 10:44 AMShattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D.globenewswire.com - March 4 at 7:00 AMBuy Rating Justified: Shattuck Labs’ Breakthrough in Cancer Immunotherapy and Strong Financialsmarkets.businessinsider.com - March 2 at 3:44 PMShattuck Labs, Inc. (NASDAQ:STTK) Sees Significant Increase in Short Interestmarketbeat.com - March 1 at 1:38 PMShattuck Labs' (STTK) "Buy" Rating Reiterated at Needham & Company LLCmarketbeat.com - March 1 at 8:28 AMShattuck Labs (STTK) Receives a Buy from TD Cowenmarkets.businessinsider.com - March 1 at 1:13 AMShattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlightsglobenewswire.com - February 29 at 4:05 PMShattuck Labs Announces Participation in Upcoming March Conferencesglobenewswire.com - February 26 at 7:00 AMSTTK Mar 2024 17.500 callfinance.yahoo.com - February 23 at 8:33 AMShattuck Labs (STTK) Set to Announce Quarterly Earnings on Fridaymarketbeat.com - February 22 at 8:45 AMShattuck Labs Stock (NASDAQ:STTK) Dividends: History, Yield and Datesbenzinga.com - February 21 at 11:19 PMSTTK Mar 2024 5.000 putfinance.yahoo.com - February 17 at 6:48 PMSTTK Mar 2024 10.000 callfinance.yahoo.com - February 17 at 8:47 AMSTTK Mar 2024 10.000 putfinance.yahoo.com - February 17 at 8:47 AMBuy Rating Affirmed: Shattuck Labs’ Promising Partnerships and Clinical Advancementsmarkets.businessinsider.com - February 14 at 3:34 PMOno Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteinsprnewswire.com - February 14 at 5:06 AMAnalysts Offer Insights on Healthcare Companies: Haemonetics (HAE) and Shattuck Labs (STTK)markets.businessinsider.com - February 13 at 2:38 PMShattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseasesfinance.yahoo.com - February 13 at 9:38 AMAnalysts Are Bullish on These Healthcare Stocks: BioNTech SE (BNTX), Molina Healthcare (MOH)markets.businessinsider.com - February 12 at 1:36 PMShattuck Labs, Inc. (NASDAQ:STTK) Sees Large Decrease in Short Interestmarketbeat.com - January 26 at 5:21 PMShattuck Labs files to sell 3.1M shares for its holdersmsn.com - January 24 at 9:12 PMShattuck Labs, Inc. (NASDAQ:STTK) CFO Andrew R. Neill Sells 25,000 Sharesmarketbeat.com - January 16 at 6:49 PMShattuck Labs, Inc. (NASDAQ:STTK) Short Interest Updatemarketbeat.com - January 13 at 8:53 PMHC Wainwright Research Analysts Boost Earnings Estimates for Shattuck Labs, Inc. (NASDAQ:STTK)marketbeat.com - January 11 at 7:58 AMHC Wainwright Weighs in on Shattuck Labs, Inc.'s FY2028 Earnings (NASDAQ:STTK)marketbeat.com - January 10 at 8:30 AMBuy Rating Affirmed for Shattuck Labs on Promising Clinical Results and Strong Financial Footingmarkets.businessinsider.com - January 10 at 12:23 AM Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address RSVP: Charles Payne’s Cash Flow Workshop (Ad)Are you ready to find untapped value in the stocks you already own… Without selling a single share… Then you need to know these Cash Flow Trade Strategies. Register For Free Now! STTK Media Mentions By Week STTK Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. STTK News Sentiment▼0.130.56▲Average Medical News Sentiment STTK News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. STTK Articles This Week▼61▲STTK Articles Average Week Get Shattuck Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for STTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Oculis News Today Travere Therapeutics News Today KalVista Pharmaceuticals News Today Altimmune News Today Verve Therapeutics News Today Larimar Therapeutics News Today Adlai Nortye News Today COMPASS Pathways News Today Arbutus Biopharma News Today Astria Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:STTK) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shattuck Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
